Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder

Personalizing treatment for late-life depression requires identifying and integrating information from multiple factors that influence treatment efficacy (moderators). We performed exploratory moderator analyses using data from a multi-site, randomized, placebo-controlled, double-blind trial of arip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Psychiatr Res
Hauptverfasser: Smagula, Stephen F., Wallace, Meredith L., Anderson, Stewart J., Karp, Jordan F., Lenze, Eric J., Mulsant, Benoit H., Butters, Meryl A., Blumberger, Daniel M., Diniz, Breno S., Lotrich, Francis, Dew, Mary Amanda, Reynolds, Charles F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021594/
https://ncbi.nlm.nih.gov/pubmed/27438687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2016.07.005
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge